fbpx
Medical Innovation Exchange

Quince hoping to sweeten its fruit with acquisitions, out-licensing of legacy Cortexyme assets

https://www.fiercebiotech.com/biotech/quince-hoping-sweeten-its-fruit-new-strategic-plan-acquisitions-and-out-licensing-legacy

Leave a Comment

Your email address will not be published.

Leave the field below empty!

This site uses Akismet to reduce spam. Learn how your comment data is processed.